These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35895049)

  • 41. Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.
    Rogers WA; Mintzker Y
    Ann Intern Med; 2018 Nov; 169(10):738-739. PubMed ID: 30452569
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates.
    Blom EF; Ten Haaf K; de Koning HJ
    Lung Cancer; 2020 Jan; 139():200-206. PubMed ID: 31816564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
    Pathirana T; Hayen A; Doust J; Glasziou P; Bell K
    BMJ Open; 2019 Mar; 9(3):e022457. PubMed ID: 30858156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Editorial: Challenges in Quantifying Overdiagnosis.
    Baker SG; Prorok PC; Kramer BS
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117354
    [No Abstract]   [Full Text] [Related]  

  • 46. Preventing overdiagnosis in mammography screening - a public health perspective.
    Concin H; Nagel G
    Horm Mol Biol Clin Investig; 2017 Dec; 32(1):. PubMed ID: 29252194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. It is overtreatment, not overdiagnosis.
    Patel TY
    Acad Radiol; 2015 Aug; 22(8):1044-5. PubMed ID: 26100201
    [No Abstract]   [Full Text] [Related]  

  • 48. The burden of malignant melanoma--lessons to be learned from Austria.
    Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
    Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do competing causes of mortality contribute to overdiagnosis in lung cancer screening?
    Durham DD; Croswell JM; Marcus PM
    Lung Cancer; 2021 Mar; 153():21-24. PubMed ID: 33445120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of the 'cancer effect' on young women's responses to overdiagnosis in cervical screening.
    Phillips K; Hersch J; Turner R; Jansen J; McCaffery K
    Patient Educ Couns; 2016 Oct; 99(10):1568-75. PubMed ID: 27133918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Breast Cancer Screening Frequency and Overdiagnosis.
    Ponti A; Frigerio A; Marra V; Armaroli P; Segnan N
    J Am Coll Radiol; 2017 Dec; 14(12):1520. PubMed ID: 29202932
    [No Abstract]   [Full Text] [Related]  

  • 52. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overdiagnosis of breast cancer at screening is clinically insignificant.
    Feig SA
    Acad Radiol; 2015 Aug; 22(8):961-6. PubMed ID: 25797300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.
    Van Poppel H; Hogenhout R; Albers P; van den Bergh RCN; Barentsz JO; Roobol MJ
    Eur Urol; 2021 Mar; 79(3):327-329. PubMed ID: 33384200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of pre-invasive disease in overdiagnosis: A microsimulation study comparing mass screening for breast cancer and cervical cancer.
    van Luijt PA; Rozemeijer K; Naber SK; Heijnsdijk EA; van Rosmalen J; van Ballegooijen M; de Koning HJ
    J Med Screen; 2016 Dec; 23(4):210-216. PubMed ID: 27068430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is overdiagnosis and why should we take it seriously in cancer screening?
    Carter SM; Barratt A
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot.
    Kalager M; Wieszczy P; Lansdorp-Vogelaar I; Corley DA; Bretthauer M; Kaminski MF
    Gastroenterology; 2018 Sep; 155(3):592-595. PubMed ID: 30076834
    [No Abstract]   [Full Text] [Related]  

  • 60. Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
    Hakama M; Malila N
    J Med Screen; 2019 Sep; 26(3):135-138. PubMed ID: 30987504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.